Snowball Research
Snowball Research
Designer and creator.
⌘K
  • Activism Weekly
  • List of companies
  • Activist Profile
  • Letter/presentation
  • About
Subscribe Sign in

Activist Letters and Presentations

A curated feed of letters and presentations from activist investors.

activistletters

Founder Al Hartman Rallies Shareholders of Silver Star Properties (SLVS) to Reclaim Company Integrity and Pursue Liquidation Plan

Summary Al Hartman and the Hartman Shareholder Alliance released a letter urging Silver Star Properties investors to vote Blue in
Oct 10, 2025
activistletters

Hartman Shareholder Alliance Urges Silver Star Properties (SLVS) Investors to Vote Blue, Citing Mismanagement and Loan Defaults

Restoring Integrity to Silver Star October 8, 2025 Dear Shareholder, A new feature published this week, "Real Estate Veteran
Oct 10, 2025
activistletters

Broadwood Partners Questions STAAR Surgical (STAA) Board’s Diligence After CEO and Chair Withhold Acquisition Interest During Alcon Deal Review

Summary Broadwood Partners, which owns 27.5% of STAAR Surgical, sent a letter to the company’s board criticizing its
Oct 10, 2025
activistletters

Broadwood Partners (27.5% Holder) Blasts STAAR Surgical (STAA) Board for Rushing to Reaffirm Alcon (NYSE: ALC) Sale Amid Fiduciary Concerns

Broadwood Partners Issues Letter to STAAR Surgical’s Board Questioning Its Diligence in Rush to Reaffirm Support for Alcon Sale
Oct 10, 2025
activistletters

Two Seas Capital Challenges Core Scientific–CoreWeave (CORZ) Deal, Citing Governance Failures and Inadequate Merger Price

Summary Two Seas Capital, a 6.5% shareholder of Core Scientific, urges investors to vote against the proposed all-stock merger
Oct 10, 2025
activistletters

Two Seas Capital LP Urges Core Scientific (CORZ) Shareholders to Reject CoreWeave Merger Over Flawed Process and Undervaluation

Company Name: Core Scientific, Inc. Symbol: CORZ Filing Date: Oct-10-2025 Filer Name: Two Seas Capital LP Download PresentationTwo Seas Capital
Oct 10, 2025
activistletters

Chip Wilson Criticizes Lululemon (LULU) Directors for Finance-Driven Decline, Urges Return to Innovation and Founder-Led Values

Summary Chip Wilson, founder of lululemon, criticized the company’s current board and leadership for abandoning its original product-driven, innovative
Oct 8, 2025
activistletters

Lululemon (LULU) Founder Chip Wilson Slams Board for Losing Brand Vision and Creative Culture, Calls for Product-Led Revival

lululemon: in a Nosedive When I founded lululemon in 1998, it was built on a relentless focus on innovation, product,
Oct 8, 2025
activistletters

Biglari Capital (3% Holder) Blasts Cracker Barrel (CBRL) Board for Strategic Failures, Demands CEO Ouster and Accountability After $700 Million Rebrand Collapse

Summary Sardar Biglari of Biglari Capital, owning about 3% of Cracker Barrel, condemned the company’s leadership for repeated strategic
Oct 8, 2025
activistletters

Biglari Capital Urges Cracker Barrel (CBRL) Shareholders to Vote Against CEO Julie Masino and Director Gilbert Dávila Over Brand Missteps and Value Destruction

BIGLARI CAPITAL CORP. 19100 RIDGEWOOD PARKWAY, SUITE 1200 SAN ANTONIO, TEXAS 78259 TELEPHONE (210) 344-3400 FAX (210) 344-3411 SARDAR BIGLARI,
Oct 8, 2025
activistletters

Broadwood Partners Urges STAAR Surgical (STAA) Shareholders to Reject Alcon (ALC) Deal, Citing Misleading Projections and Flawed Fairness Opinion

Summary Broadwood Partners, STAAR Surgical’s largest shareholder with a 27.5% stake, accused the company’s management of manipulating
Oct 8, 2025
activistletters

Broadwood Partners (27.5% Shareholder) Accuses STAAR Surgical (STAA) of Manipulating Forecasts to Justify Undervalued Sale to Alcon (ALC)

Broadwood Partners Questions Integrity of STAAR Surgical’s Last-Minute Forecast Change and Fairness Opinion in Sale to Alcon Conflicted Management
Oct 8, 2025
activistletters

Yunqi Capital urges STAAR Surgical (STAA) shareholders to vote against Alcon deal; pushes cost cuts, buybacks, and stronger standalone strategy

Summary Yunqi Capital (5.1% holder) urges STAAR shareholders to vote against Alcon’s proposed $28-per-share merger, arguing STAAR is
Oct 7, 2025
activistletters

Yunqi Capital opposes STAAR Surgical (STAA)–Alcon merger, citing China strength, undervaluation, and misaligned CEO incentives

Yunqi Capital, One of STAAR Surgical Company’s Largest Shareholders, Reiterates Its Opposition to the Proposed Merger with Alcon STAAR
Oct 7, 2025
activistletters

Al Hartman Accuses Silver Star (STSR) Board of Obstruction, Urges Shareholders to Support Liquidation and Accountability

Summary On October 3, 2025, Al Hartman and the Hartman Shareholder Alliance accused Silver Star’s board of repeatedly delaying
Oct 7, 2025
activistletters

Hartman Shareholder Alliance Challenges Silver Star (STSR) Board Over Vote Delays and Shareholder Rights

Exposing Delay Tactics & False Claims October 3, 2025 Dear Shareholder, Silver Star has delayed this vote five times already
Oct 7, 2025
activistletters

Broadwood Capital’s Neal Bradsher Slams STAAR Surgical (STAA) Board for Approving $28 Sale, Urges Shareholders to Vote Against Deal

Summary Broadwood Capital’s Neal Bradsher criticized STAAR Surgical’s board for agreeing to sell the company to Alcon for
Oct 6, 2025
activistletters

Broadwood Partners (27.5%) Opposes STAAR Surgical (STAA) Sale to Alcon, Citing Board’s Misjudgment After Rejecting $58 Offer

Dear Members of the Board: You have decided it is time to sell STAAR for $28 per share. As you
Oct 6, 2025
Snowball Research © 2026. Published with Ghost & Braun
  • Sign up